10 Apr 2019

Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

NaTHNaC receives reassurance that contingencies for continuous yellow fever vaccine supply to the UK are robust and sustainable in the event of a ‘no deal’ EU Exit Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

On behalf of Yellow Fever Vaccination Centres (YFVC) in England, Wales and Northern Ireland, NaTHNaC has been working closely with Sanofi Pasteur who manufacture, pack and supply yellow fever vaccine in France for the UK market. Sanofi Pasteur advises that their contingency plan for a ‘no deal’ EU Exit includes increasing yellow fever vaccine stock levels and securing alternative and robust supply lines into the UK.

Local stockpiling is unnecessary and YFVC should continue to order YF vaccine as usual.

Further updates will be provided when available.

Resources

COVID-19 resources available on TravelHealthPro

Many countries in the world are now affected by an outbreak of Coronavirus disease 2019 (COVID-19) Read more

Change to telephone advice line opening hours for health professionals

The advice line opening hours are changing from 23 March 2020 Read more

Rabies detected in a puppy imported to France

The dog located in Île de Ré developed symptoms on 1 February Read more

Ebola virus disease (EVD): Democratic Republic of Congo- update

World Health Organization declares that the outbreak in DRC still constitutes a public health emergency of international concern (PHEIC) under the IHR (2005) Read more

YFVC registration: new online payment system

Important notice from NaTHNaC for all yellow fever vaccination centres (England, Wales and Northern Ireland) Read more
Back to Top

VIEW FULL INDEX